C. Suen

发表

Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers

R. Shoemaker, Altaf Mohammed, R. Lubet, 2019, Cancer Prevention Research.

The potential of incretin-based therapies in type 1 diabetes.

C. Suen, P. Burn, 2012, Drug discovery today.

Abstract 2820: Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model

V. Steele, C. Rao, J. Patlolla, 2015 .

Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice

V. Steele, F. Ondrey, M. G. O’Sullivan, 2016, Cancer Prevention Research.

Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design.

J. Luz, D. Clawson, C. Suen, 2014, Journal of medicinal chemistry.

Identification and Characterization of Hamster Stearoyl-CoA Desaturase Isoforms

Y. Qian, C. Suen, Lan Yu, 2008, Lipids.

A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance

H. Parnes, KyungMann Kim, H. Mukhtar, 2020, The Prostate.

Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma

V. Steele, C. Rao, Yuting Zhang, 2019, Cancer Prevention Research.

PGC-1 Functions as a Transcriptional Coactivator for the Retinoid X Receptors*

C. Suen, W. Chin, P. Delerive, 2002, The Journal of Biological Chemistry.

Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin.

C. Chang, C. Suen, C. Chou, 1987, The Journal of clinical investigation.

The NCI’s PREVENT Cancer Preclinical Drug Development Program: Overview, Current Projects, Animal Models, Agent Development Strategies, and Molecular Targets

V. Steele, R. Shoemaker, C. Suen, 2016 .

Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice

C. Suen, T. Fitch, Angela M. Siesky, 2015, PloS one.

Rapid inactivation and phosphorylation of pyroglutamyl peptidase II in Y-79 human retinoblastoma cells after exposure to phorbol ester.

C. Suen, S. Wilk, 1990, Endocrinology.

Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.

C. Suen, S. Wilk, 1987, Endocrinology.

Ligand-dependent, Pit-1/growth hormone factor-1 (GHF-1)-independent transcriptional stimulation of rat growth hormone gene expression by thyroid hormone receptors in vitro

C. Suen, W. Chin, 1993, Molecular and cellular biology.

Inhibition of pyroglutamyl peptidase II synthesis by phorbol ester in the Y-79 retinoblastoma cell.

C. Suen, S. Wilk, 1991, Endocrinology.

Sodium butyrate induces pyroglutamyl peptidase I and decreases thyrotropin-releasing hormone receptors in GH3 cells.

C. Suen, S. Wilk, 1989, Endocrinology.

Regulation of Thyrotropin Releasing Hormone Degrading Enzymes in Rat Brain and Pituitary by L‐ 3,5,3′‐Triiodothyronine

C. Suen, S. Wilk, 1989, Journal of neurochemistry.

Targeting cholecystokinin‐2 receptor for pancreatic cancer chemoprevention

C. Rao, Altaf Mohammed, S. Lightfoot, 2019, Molecular carcinogenesis.

Insulin suppresses hepatitis B surface antigen expression in human hepatoma cells.

C. Chang, C. Suen, C. Chou, 1989, The Journal of biological chemistry.

Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden

R. Yantiss, E. Pamer, Lilan Ling, 2016, Cancer Prevention Research.

TRAM-1, A Novel 160-kDa Thyroid Hormone Receptor Activator Molecule, Exhibits Distinct Properties from Steroid Receptor Coactivator-1*

N. Koibuchi, C. Suen, W. Chin, 1997, The Journal of Biological Chemistry.

The National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets.

V. Steele, R. Shoemaker, C. Suen, 2016, Seminars in oncology.

Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis*

A. R. Miller, G. Etgen, C. Broderick, 2003, The Journal of Biological Chemistry.

Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation.

D. Ray, A. Brass, C. Suen, 1999, Molecular endocrinology.

A Transcriptional Coactivator, Steroid Receptor Coactivator-3, Selectively Augments Steroid Receptor Transcriptional Activity*

C. Lyttle, C. Suen, D. Frail, 1998, The Journal of Biological Chemistry.

Identification of Reverbα as a Novel RORα Target Gene*

C. Suen, W. Chin, P. Delerive, 2002, The Journal of Biological Chemistry.

Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women

B. Dunn, C. Suen, A. Decensi, 2016, Expert review of clinical pharmacology.

A phase IIa randomized placebo-controlled trial of pomegranate fruit extract/POMx in subjects with clinically localized prostate cancer undergoing active surveillance.

H. Parnes, KyungMann Kim, H. Mukhtar, 2020 .

A potential transcriptional adaptor(s) may be required in thyroid hormone-stimulated gene transcription in vitro.

C. Suen, W. Chin, 1995, Endocrinology.

Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer

V. Steele, C. Rao, Yuting Zhang, 2017, Oncotarget.

Occurrence of pyroglutamyl peptidase II, a specific TRH degrading enzyme in rabbit retinal membranes and in human retinoblastoma cells

C. Suen, S. Wilk, E. Wilk, 1988, Neuropeptides.

currence of Pyroglutamyl Peptidase ti, egrading Enzyme in Rabbit Retinal embrane and in Huma Retinoblastom

C. Suen, Elizabeth K. WlLK, 1988 .

Identification of Reverb(alpha) as a novel ROR(alpha) target gene.

C. Suen, W. Chin, P. Delerive, 2002, The Journal of biological chemistry.

Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat

V. Steele, C. Rao, Yuting Zhang, 2021, Cancer Prevention Research.

Abstract 4983: Intermittent dosing regimens of naproxen and aspirin inhibit azoxymethane-induced rat colon adenoma progression to adenocarcinoma and carcinoma invasion

V. Steele, C. Rao, Yuting Zhang, 2018, Prevention Research.

The potential of incretin-based therapies in type 1 diabetes.

C. Suen, P. Burn, 2012, Drug discovery today.